laurolistine
- 中文别名：去甲异波尔定
- 中文释义：新木姜子碱;去甲异波尔定;(S)-5,6,6A,7-四氢-1,10-二甲氧基-4H-二苯并[DE,G]喹啉-2,9-二醇
- 英文别名：laurolistine;
Laurolistine;
Norisoboidine;
LAUROLITSINE;
Norboldine
- CAS No.：5890-18-6
- 分子式：
C18H19NO4
- 分子量：313.34800
- 精确分子量：313.13100
- PSA：70.95000
- InChI：The Key: KYVJVURXKAZJRK-LBPRGKRZSA-N
- 分子结构式：
物化性质
- 密度：
- 1.313
- 熔点：
- 138-140ºC
- 沸点：
- 553ºC at 760mmHg
- 闪点：
- 288.3ºC
安全信息
- 密度：
- 1.313
- 熔点：
- 138-140ºC
- 沸点：
- 553ºC at 760mmHg
- 闪点：
- 288.3ºC
毒理性
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- RB5935000
- CHEMICAL NAME :
- 6a-alpha-Noraporphine-2,9-diol, 1,10-dimethoxy-
- CAS REGISTRY NUMBER :
- 5890-18-6
- LAST UPDATED :
- 198208
- DATA ITEMS CITED :
- 3
- MOLECULAR FORMULA :
- C18-H19-N-O4
- MOLECULAR WEIGHT :
- 313.38
- WISWESSER LINE NOTATION :
- T C6666 1A Q KM&TT&J EO1 FQ PQ QO1
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 450 mg/kg
- TOXIC EFFECTS :
- Cardiac - change in rate Vascular - BP lowering not characterized in autonomic section Lungs, Thorax, or Respiration - other changes
- REFERENCE :
- APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1943- Volume(issue)/page/year: 38,537,1980
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 170 mg/kg
- TOXIC EFFECTS :
- Cardiac - change in rate Vascular - BP lowering not characterized in autonomic section Lungs, Thorax, or Respiration - other changes
- REFERENCE :
- APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1943- Volume(issue)/page/year: 38,537,1980
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 90 mg/kg
- TOXIC EFFECTS :
- Cardiac - change in rate Vascular - BP lowering not characterized in autonomic section Lungs, Thorax, or Respiration - other changes
- REFERENCE :
- APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1943- Volume(issue)/page/year: 38,537,1980
热门化工词典词汇
- 3-Pyridinemethanol,5,6-dichloro-5,6-二氯-3-嘧啶甲醇
- dimethyl bicyclo[2.2.1]heptane-2,3-dicarboxylatedimethyl bicyclo[2.2.1]heptane-2,3-dicarboxylate
- 3,4-dibromonaphthalene-1,2-dione3,4-二溴-1,2-萘二酮
- 1-bromo-6-methylcyclohexene1-溴-6-甲基环己烯
- 4-(6-Methoxy-pyriMidin-4-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester4-(6-甲氧基-嘧啶-4-基氨基)-哌啶-1-羧酸叔丁基酯
- 1,1'-(1,3-Propanediyl)bis[1,1-bis(2-methoxy-5-methylphenyl)phosphine]1,1'-(1,3-丙二基)双[1,1-双(2-甲氧基-5-甲基苯基)膦]
- 5-methylsulfonylthiophene-2-carbaldehyde5-(甲基磺酰基)-2-噻吩甲醛
- 2-Propenoicacid,2-hydroxyethylester,polymerwith.alpha.-hydro-.omega.-hydroxypoly(oxy-1,4-butanediyl)and1,1-methylenebis[42-丙烯酸-2-羟乙基酯与&alpha
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-methyl-5-METHYLPYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE
- 5-(1-ethyl-5-methylpyrazol-4-yl)-1,2-oxazole-3-carboxylic acid5-(1-乙基-5-甲基-1H-吡唑-4-基)-异恶唑-3-羧酸
